First Yaz Trial Postponed

Yaz and Yasmin are birth control contraceptives which contain the hormone drospirenone.  These contraceptives, manufactured by Bayer (Germany’s largest drugmaker), have been the focus of regulators due to potential safety issues, including potential increase risks of deep vein thrombosis, pulmonary embolisms, and gall bladder disease.  There are currently over 10,000 lawsuits alleging injuries due to Yaz and Yasmin.

A series of important trials had been scheduled to begin this year accusing Bayer of misleading women regarding Yasmin and Yaz’s health risks.  These trials would have served as so called “bellwether trials” (which are often used to indicate future trends in a given litigation) on the Yaz/Yasmin litigation.  However, U.S. District Judge David Herndon in Illinois postponed the Jan. 9th trial last week, and ordered the two sides to work with  a mediator, Stephen Saltzburg.  Saltzburg is a George Washington University law professor who will work with both sides to look into the possibility of settlement.

More information can be found on